GLP-1 Telehealth: What Prescribers Need to Know in California

You’re seeing it in your practice already: patients gaining 30+ pounds on antipsychotics, asking about ‘those weight-loss shots everyone’s talking about,’ and struggling with both their mental health and metabolic complications. Meanwhile, GLP-1 drugs like Ozempic and Wegovy are everywhere — and 6% of Americans (roughly 20 million people) are now taking them for weight loss. That number has grown 600% in just six years.

Here’s the opportunity most psychiatrists are missing: you’re uniquely positioned to meet this demand. You already manage chronic conditions, understand behavior change, and have existing patient relationships. Unlike primary care docs drowning in 15-minute appointments, you can actually build sustainable weight management into your practice — and do it profitably without adding overwhelming administrative burden.

But there’s a catch: scaling a GLP-1 practice the wrong way is a fast track to burnout. This guide shows you how to do it right — from patient acquisition and telehealth compliance to workflow optimization and real economics.

The Business Case: Why Psychiatrists Are Entering the GLP-1 Market

The Demand Is Real (and It’s Not Slowing Down)

Nearly 75% of Americans are overweight or obese. That’s not a niche market — that’s a national health crisis creating massive patient demand. By 2024, about 2% of Americans were using GLP-1 medications specifically for obesity. By 2025, that tripled to 6%, with tens of thousands of new patients starting treatment each week.

For context: there are only about 7,000 board-certified obesity medicine specialists in the U.S. Do the math — the supply-demand gap is enormous, and patients are searching for providers who can prescribe these medications.

Psychiatry’s Natural Advantage

Nearly half of psychiatrists were already prescribing or recommending GLP-1 drugs as of late 2023, often to address medication-induced weight gain or co-morbid obesity. You’re already having these conversations. The question is whether you’re monetizing them.

Consider what you bring to weight management that most providers don’t:

• Expertise in behavior change — Weight loss isn’t just about medication; it’s about motivation, adherence, and managing setbacks. You already do this work.
• Mental health integration — Many patients struggle with binge eating, emotional overeating, depression, or anxiety that sabotage weight loss. You can address root causes, not just prescribe pills.
• Ongoing relationships — Unlike one-off urgent care visits, you see patients regularly. That continuity is gold for weight management, which requires months of support.
• Telehealth fluency — Most psychiatrists pivoted to virtual care during COVID and never looked back. GLP-1 weight management is perfect for telehealth (more on compliance below).

The business model is straightforward: patients need ongoing medication management, periodic monitoring, and behavioral support — services you’re already trained to deliver. The question is whether you structure your practice to capture this revenue stream efficiently.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

How to Get GLP-1 Patients: Marketing That Actually Works

Let’s be honest about patient acquisition. Many providers waste thousands on marketing channels that don’t convert, or they underprice their services and attract the wrong patients.

Internal Referrals: Start With Who You Already Know

The easiest patients to acquire are sitting in your current caseload. Identify patients who:

• Have gained significant weight on psychiatric medications (antipsychotics, mood stabilizers, certain antidepressants)
• Have a BMI ≥27 with comorbidities (diabetes, hypertension, sleep apnea) or BMI ≥30
• Express frustration about weight or metabolic health

Bring it up during medication reviews: ‘I know you’ve been concerned about the weight gain from your antipsychotic. I’ve started offering medical weight management with GLP-1 medications alongside your psychiatric care. Would you like to discuss whether that’s a fit for you?’

This approach has zero marketing cost and builds on existing trust. Many patients will be thrilled you’re addressing the whole picture, not just their mental health in isolation.

External Marketing: Platforms vs. DIY

For growth beyond your existing panel, you have two paths:

1. Join a Telehealth Platform

Platforms like Klarity Health (and others focused on weight management) invest heavily in patient acquisition and funnel qualified leads to enrolled providers. Instead of gambling on marketing channels, you pay only when patients book with you.

Here’s the economic reality most solo providers learn the hard way: acquiring a qualified psychiatric or weight-loss patient through DIY marketing typically costs $200-500+ when you factor in all costs — agency fees, ad spend, staff time to handle and qualify leads, no-show rates, months of SEO investment before results, and failed campaigns.

• SEO takes 6-12 months of consistent investment (content creation, technical optimization, link building) before generating meaningful patient flow. Most solo psychiatrists don’t have the expertise, time, or patience.
• Google Ads for mental health and weight-loss keywords run $15-40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200-400+, and you’re competing with huge telehealth companies that outspend you 100:1.
• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of providers on the same page. Zocdoc charges per booking ($35-100+), but total monthly cost including the subscription adds up fast.

Contrast that with a platform model: you pay a standard listing fee per new patient lead (similar to Zocdoc’s per-booking fee), but the key differences are:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty, availability, and geographic area
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure — no separate platform costs
• Both insurance and cash-pay patient flow depending on your preference
• You control your schedule — only pay when you actually see patients

Frame it this way: instead of spending $3,000-5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. That’s guaranteed ROI vs. gambling on marketing channels where you could blow through your budget before seeing a single patient.

2. DIY Marketing (For Those With Budget and Patience)

If you have the resources and long-term vision, building your own patient acquisition engine can eventually be cost-effective. This means:

• SEO: Create content targeting searches like ‘psychiatrist for weight loss near me,’ ‘GLP-1 prescribing doctor [your city],’ or ‘mental health and weight management.’ Optimize your Google Business Profile. Expect 6-12 months before meaningful traffic.
• Social media: Share patient success stories (with permission), educate about the mental health-obesity connection, or post about medication-induced weight gain. Instagram and Facebook work well for local targeting.
• Referral relationships: Build partnerships with therapists, dietitians, primary care docs, and endocrinologists. Let them know you offer comprehensive weight management with psychiatric expertise. These referrals often convert at higher rates because they come pre-vetted.

The reality: DIY marketing works IF you have the budget to invest for 6-12 months without immediate returns, IF you have expertise (or hire it), and IF you’re willing to experiment and iterate. For most psychiatrists — especially those starting out or already maxed on clinical hours — a platform that removes acquisition risk entirely is the smarter play.

GLP-1 Telehealth Compliance: What You Actually Need to Know

Here’s the good news: prescribing GLP-1 medications via telehealth is straightforward because these drugs are not controlled substances. The Ryan Haight Act (federal in-person exam requirement) does NOT apply to GLP-1s. That means you can legally prescribe semaglutide, tirzepatide, or similar medications via pure telehealth if you’re licensed in the patient’s state.

Licensure Basics

For Psychiatrists (MD/DO): You must hold a medical license in the state where your patient is located during the consultation. Some states (like Florida and those in the Interstate Medical Licensure Compact) offer expedited pathways for out-of-state physicians. California, New York, and Pennsylvania require full in-state licenses with no telehealth shortcuts.

For PMHNPs and Psychiatric PAs: Your ability to prescribe GLP-1s depends on state scope-of-practice laws:

• Independent Practice States: California (starting 2026 for experienced NPs), New York (after 3,600 practice hours), Illinois (after 4,000 hours + additional coursework) allow NPs to practice without physician oversight once qualified.
• Collaborative Practice States: Texas, Pennsylvania, and Florida require NPs to maintain physician collaboration agreements. Your supervising physician must be available for consult and periodically review charts.

Bottom line: if you’re a psychiatrist, you’re good to go in any state where you hold a license. If you’re an NP, check your state’s requirements and ensure you have appropriate supervision if needed.

Standard of Care for Telehealth GLP-1 Prescribing

Meeting the standard of care via telehealth means conducting a thorough evaluation equivalent to what you’d do in person:

1. Comprehensive intake: Weight history, dietary habits, physical activity, medical conditions (especially contraindications like medullary thyroid cancer, pancreatitis history), current medications, mental health status.
2. Informed consent: Discuss realistic weight-loss expectations (10-15% body weight over 6-12 months), potential side effects (nausea, GI upset), cost (especially if insurance doesn’t cover), and the need for ongoing lifestyle changes.
3. Baseline labs: A1c, fasting glucose, liver enzymes, TSH if indicated. You can order these through LabCorp/Quest and have patients get them locally or via mobile phlebotomy.
4. Documentation: Chart your assessment, diagnosis (obesity, overweight with comorbidities), treatment plan, and patient education. If using semaglutide off-label for obesity (vs. the FDA-approved Wegovy), document your rationale.

No state prohibits GLP-1 prescribing via telehealth for obesity as long as these standards are met. Several states (like Texas and Florida) explicitly allow establishing the patient-practitioner relationship via synchronous audio-visual consult with no in-person requirement.

Mental Health Monitoring: Your Unique Contribution

There’s been media attention on potential psychiatric side effects of GLP-1s — including rare reports of suicidal ideation. By early 2026, the FDA reviewed data and found no clear causal link, directing removal of suicide warnings from labels. Still, as a psychiatrist, you should:

• Screen for mood or anxiety changes at each follow-up
• Ask specifically about motivation, energy, and suicidal thoughts (as you would in any psychiatric evaluation)
• Educate patients that weight loss itself can sometimes trigger mood changes (both positive and negative)

This vigilance is a value-add that distinguishes you from non-psychiatric weight-loss clinics. Patients appreciate that their provider understands the mental health dimension.

State-Specific Nuances (Priority States)

Cash-Pay vs. Insurance: The Economics of GLP-1 Practice

Most weight-loss telehealth practices favor cash-pay models for a simple reason: insurance coverage for obesity medications is limited and inconsistent.

The Insurance Reality

• Most insurers cover GLP-1 drugs for diabetes, but coverage for obesity is spotty. As of mid-2024, only 13 state Medicaid programs (including CA, PA, and IL) covered GLP-1s for weight loss.
• Many commercial plans explicitly exclude weight-loss medications or require extensive prior authorizations with high denial rates.
• As a result, most patients pay out-of-pocket for the medications themselves — whether that’s $1,300/month for brand-name Wegovy or a few hundred for compounded semaglutide.

This creates patient self-selection: people willing to pay cash for meds are often willing to pay cash for visits, too.

Cash-Pay Model: Pros and Cons

Pros:

• Simple operations (no prior auths, no billing headaches)
• Higher revenue per visit (charge $150-300 for initial consult, $75-150 for follow-ups)
• Direct payment (no insurance delays or denials)
• Pairs naturally with patients already paying cash for meds

Cons:

• Limits patient pool to those who can afford out-of-pocket costs
• May feel exclusionary (though many offer sliding scales or payment plans)
• No insurance ‘stamp of approval’ (some patients prefer insurance coverage for legitimacy)

Many practices charge a monthly subscription (e.g., $199/month) that includes medication management visits, messaging access, and sometimes the medication itself (via compounded sources). This predictable revenue is attractive, but requires consistent patient retention.

Insurance Model: Pros and Cons

Pros:

• Wider patient access (especially Medicaid or patients with good coverage)
• Potential for higher volume (patients who wouldn’t pay cash can afford copays)
• Legitimacy and trust (insurance billing signals ‘real medical care’)

Cons:

• Prior authorization hell (expect to spend staff time appealing denials)
• Lower reimbursement (E/M codes pay less than cash-pay rates)
• Administrative burden (credentialing, claims, coordination with pharmacies)

Hybrid Approach (The Smart Middle Ground):

Charge cash for the initial comprehensive evaluation (which takes 45-60 minutes and includes extensive education and goal-setting). Then offer patients the option to:

• Continue cash-pay for follow-ups (often simpler), OR
• Use insurance for follow-ups if they have coverage (bill standard E/M codes or obesity counseling codes like G0447)

This way, you capture upfront revenue for your most time-intensive work, and patients appreciate the flexibility.

Scaling Without Burning Out: Workflows That Work

The biggest mistake psychiatrists make when adding GLP-1 services is treating every patient like a complex psychiatric case. Weight management follow-ups can be streamlined without sacrificing quality.

Optimize Your Intake Process

Before the first visit:

• Send digital intake forms covering weight history, diet/exercise patterns, medical conditions, medications, and mental health screening
• Order baseline labs (A1c, TSH, liver panel) so results are ready by visit 1
• Have patients submit current weight, height, and photos (optional but helpful for tracking)

During the first visit (45-60 min):

• Review intake and labs
• Assess appropriateness for GLP-1 therapy (BMI, contraindications)
• Educate on medication (injection technique, side effects, realistic expectations)
• Set weight-loss goal and discuss lifestyle changes (diet, exercise, sleep)
• Screen mental health (mood, eating behaviors, motivation)
• Prescribe starting dose and schedule follow-up

Use templated documentation to streamline charting. Create an ‘Obesity Initial Consult’ note template that prompts you to cover all key elements without writing from scratch each time.

Streamline Follow-Ups (15-20 min)

Monthly follow-ups during dose escalation can be brief:

• Review weight change since last visit (patients can report via portal before the visit)
• Ask about side effects (nausea, constipation, energy)
• Screen mood/mental health changes
• Adjust dose per protocol (most GLP-1s have standard titration schedules)
• Reinforce lifestyle habits

Delegation is key: Train a medical assistant or RN to gather interval data (weight, blood pressure, symptom questionnaire) before the visit. You review it and spend your 15 minutes on clinical decision-making and counseling, not data collection.

Once patients are stable on maintenance dose, space visits to every 2-3 months with brief asynchronous check-ins (portal messages or app updates) in between.

Leverage Technology

• Telehealth platform with integrated scheduling/video/e-prescribing (reduces tech friction)
• Patient portal for messaging (handle simple questions asynchronously: ‘Is nausea normal?’ → ‘Yes, here’s how to manage it.’)
• Automated reminders for appointments, lab work, and weight tracking
• Remote monitoring tools like connected scales or apps where patients log weight weekly (you can review trends at a glance)

Some practices use group visits for ongoing education and support (e.g., monthly 30-min group Zoom for patients on GLP-1s). This offloads repetitive counseling, provides peer support, and improves retention — all while scaling your time.

Build a Team (Even If It’s Small)

You don’t need a full clinic staff, but consider:

• Health coach or RN to handle lifestyle counseling, answer routine questions, and triage issues
• Virtual assistant for scheduling, insurance verification, and patient intake coordination
• Collaborating physician (if you’re an NP) who’s available for consult but not hands-on with every patient

This team-based care model lets you focus on prescribing decisions and complex cases while others handle routine support. Result: you can manage 100+ GLP-1 patients without drowning.

Set Boundaries to Prevent Burnout

The demand for GLP-1 services can feel overwhelming. Protect yourself:

• Cap daily consults: Limit GLP-1 new patients to 2-3 per day so you’re not doing back-to-back weight consults (which can feel repetitive)
• Block admin time: Schedule 30-60 min daily for charting, portal messages, and care coordination
• Define availability hours: Don’t let patient messages bleed into evenings and weekends. Use auto-replies: ‘I respond to non-urgent messages within 24 hours during business hours.’
• Take breaks: Telehealth makes it easy to skip lunch or work through breaks. Don’t. Schedule breaks between sessions.
• Maintain variety: If you’re a psychiatrist, consider keeping a mix of psych and weight-management patients to avoid monotony. Or, if you love the metabolic psychiatry intersection, lean into it fully — just be intentional.

Monitor your own burnout signs: emotional exhaustion, depersonalization (viewing patients as tasks), declining work satisfaction. If these arise, reassess workload immediately. It’s better to temporarily cap new patients than to burn out and quit altogether.

Research shows that schedule flexibility and virtual practice options significantly reduce provider burnout. You’ve already got the telehealth infrastructure — use it to design a practice that sustains you long-term.

Retention: Turning One-Time Patients Into Long-Term Revenue

GLP-1 weight management is a chronic care model. Patients typically need medication for months to years, and many regain weight if they stop. Your goal: make your practice the obvious place for ongoing support.

Retention strategies:

• Monthly check-ins (even brief ones) maintain connection and catch issues early
• Educational content: Send periodic emails or texts with tips (recipes, exercise ideas, mindset coaching)
• Celebrate milestones: Acknowledge when patients hit weight-loss goals or improve metabolic markers
• Address plateaus proactively: Weight loss often stalls after initial months. Normalize this and adjust the plan (dose increase, diet review, mental health check)
• Offer add-on services: Nutrition consults (via RD referral or in-house), mental health therapy for emotional eating, fitness coaching

Patients stay when they feel supported and seen, not just when they’re losing weight. Your psychiatric training gives you an edge here — you’re used to building therapeutic relationships and addressing ambivalence or setbacks.

The Bottom Line: GLP-1 as a Practice Growth Engine

Adding GLP-1 weight management to your psychiatric practice isn’t just a side hustle — it’s a strategic move that:

• Meets massive patient demand (20 million Americans on GLP-1s and growing)
• Leverages your existing skills (behavior change, chronic care management, telehealth)
• Generates predictable revenue (recurring visits, high patient retention)
• Differentiates your practice (integrated mental health + metabolic care is rare)

But it only works if you structure it for scalability and sustainability. That means:

• Smart patient acquisition (platforms over DIY marketing unless you have the budget)
• Efficient workflows (templated documentation, delegation, technology)
• Realistic economic model (cash-pay for simplicity, insurance if you have the infrastructure)
• Boundaries to prevent burnout (capped consults, team support, scheduled breaks)

Start small. Add 5-10 GLP-1 patients this month. Refine your intake process. Test your documentation templates. See how it feels. Then scale gradually — 20 patients, 50 patients, 100 patients.

Done right, this isn’t just more work. It’s a new service line that energizes your practice, improves patient outcomes, and grows your income — without sacrificing your well-being.

Frequently Asked Questions

Can I prescribe GLP-1 medications if I’m not board-certified in obesity medicine?

Yes. Any licensed physician can prescribe GLP-1 drugs within their scope of practice. Obesity medicine certification (ABOM) is optional but not required. As a psychiatrist, you’re already managing chronic conditions and can develop competency through CME, mentorship, or clinical experience. For off-label use (like prescribing Ozempic for obesity), document your rationale and obtain informed consent.

Do I need malpractice insurance coverage for weight-loss prescribing?

Check with your insurer. Most physician malpractice policies cover any practice within your specialty scope, which can include obesity management. However, if you’re substantially pivoting your practice (e.g., 50%+ weight-loss patients), notify your carrier and confirm coverage. NPs should verify their policy doesn’t exclude services outside their certified specialty area.

What if my state requires NP-physician collaboration and I’m a solo PMHNP?

You’ll need to partner with a collaborating physician (often called a ‘medical director’ in telehealth weight-loss companies). Some states allow remote collaboration (the MD doesn’t need to be in your office daily but must be available for consult and review charts). Alternatively, join a telehealth platform that provides supervising physicians as part of their infrastructure.

How do I handle compounded semaglutide vs. brand-name medications?

FDA-approved medications (Wegovy, Saxenda) are the gold standard but expensive. Compounded semaglutide from 503B pharmacies can be more affordable for patients. If using compounders, vet them carefully (licensed, FDA-registered, using high-quality ingredients). Document why you’re prescribing compounded vs. brand (e.g., cost, patient preference) and educate patients on the difference. The FDA has issued warnings about questionable compounding sources, so due diligence protects both you and your patients.

What’s a realistic patient volume for one psychiatrist managing GLP-1 patients?

It depends on your efficiency and support. A solo psychiatrist spending 45 min on initial consults and 15 min on follow-ups could reasonably manage:

• 10-15 new patients per month (5-6 hours clinical time)
• 50-75 active follow-up patients (12-15 hours monthly if seen every 4-6 weeks)

With delegation (health coach handling routine check-ins, group visits, etc.), that number can double. Set your own cap based on desired workload and income goals.

Will Medicare or Medicaid cover my GLP-1 visits?

As of 2026, Medicare historically did NOT cover anti-obesity medications (though pilot programs are in discussion). Some state Medicaid programs (CA, PA, IL, and ~10 others) do cover GLP-1s for obesity. You can bill standard E/M codes for obesity counseling visits, or use G0447 (intensive behavioral therapy for obesity) if you meet Medicare’s criteria. Check your state’s Medicaid formulary and prior authorization requirements before promising patients insurance coverage.

Sources

1. Axios – ‘Just how many Americans are taking GLP-1s now’ (Fair Health data on usage) – Published May 27, 2025 – www.axios.com

2. ConfectioneryNews – ‘GLP-1 drugs like Ozempic are reshaping health, diet and the food industry’ – Published Oct 20, 2025 – www.confectionerynews.com

3. Time – ‘The Heavy Cost of Using Weight-Loss Drugs to Get Skinny’ – Published Aug 22, 2025 – time.com

4. Axios – ‘America’s doctors need more obesity medicine training’ – Published May 28, 2024 – www.axios.com

5. Axios – ‘States slow to cover GLP-1s for weight loss’ – Published Nov 5, 2024 – www.axios.com

6. PharmaNewsIntelligence via Schizophrenia Forum – ‘Psychiatrists Prescribe or Recommend Ozempic’ – Published Nov 6, 2023 – forum.schizophrenia.com

7. California Board of Registered Nursing – AB 890 Implementation FAQ – Updated Nov 2024 – www.rn.ca.gov

8. MedicalDirectorCo – ‘Texas Weight Loss Clinic & Telehealth Compliance Guide’ – Published 2025 – www.medicaldirectorco.com

9. Wheel Health – ‘Florida Telehealth Regulations and Laws’ – Published 2022 (post-SB312) – www.wheel.com

10. SingleAim Health – ‘Nurse Practitioner Collaborative Agreement Templates: 50-State Guide’ – Published 2023 – www.singleaimhealth.com

11. Commonwealth of Pennsylvania – Press Release: Shapiro Administration Expands Job Opportunities via Health Compacts – Published June 23, 2025 – www.pa.gov

12. American Association of Nurse Practitioners – State Practice Environment: Illinois – Data snapshot 2023 – www.aanp.org

13. CompHealth – Interstate Medical Licensure Compact Guide – Updated 2024 – comphealth.com

14. Rivkin Rounds Healthcare Law Blog – ‘New Law Allows Experienced NPs to Practice Independently in NY’ – Published April 2022 – www.rivkinrounds.com

15. Florida Senate – Statute 464.0123 (Advanced Practice Registered Nursing) – 2023 edition – www.flsenate.gov

16. Metabolic Mind Podcast – ‘Psychiatrist shares his experience with GLP-1 weight loss drugs with Dr. Rodrigo Mansuer’ – Published 2023 – www.metabolicmind.org

17. Associated Press – ‘FDA says suicide risk warning for weight-loss drugs can be removed’ – Published Feb 2026 – apnews.com

18. Axios – ‘Medicare, Medicaid to pilot coverage of GLP-1 drugs’ – Published Aug 1, 2025 – www.axios.com

19. ScienceDirect – ‘Effects of flexible scheduling and virtual practice on provider burnout’ – Published 2022 – www.sciencedirect.com

20. TeleCareAware – ‘GLP-1 Telehealth Market Growth’ – Published 2024 – telecareaware.com

Source:

• https://www.axios.com/2025/05/27/american-glp1-use-weight-loss-increasing#:~:text=More%20than%202,their%20original%20approved%20use
• https://www.confectionerynews.com/Article/2025/10/20/glp-1-drugs-like-ozempic-are-reshaping-health-diet-and-the-food-industry/#:~:text=GLP,real%20number%20according%20to%20Kim
• https://forum.schizophrenia.com/t/psychiatrists-recommend-ozempic/311318#:~:text=Drugs%20pharmanewsintel
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=equivalent%20to%20in,FDA%2C%20pharmacy%2C%20and%20board%20alerts
• https://www.medicaldirectorco.com/texas-weight-loss-clinic-telehealth-compliance-guide/#:~:text=,with%20chart%20review%2C%20plus%20meetings
• https://www.singleaimhealth.com/news/nurse-practitioner-collaborative-agreement-templates-50-state-guide#:~:text=In%20Pennsylvania%2C%20Certified%20Registered%20Nurse,the%20CRNP%20and%20the%20collaborating
• https://www.wheel.com/state-telehealth-regulations/florida#:~:text=Are%20There%20Online%20Prescription%20Restrictions,for%20Telehealth%20in%20Florida
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=most%20insurances%20cover%20the%20medication,A%20recent%20Annals%20of%20Internal
• https://www.axios.com/2024/11/05/states-slow-to-cover-glp-1s-for-weight-loss#:~:text=What%20they%20found%3A%20In%20all%2C,a%20primary%20concern%2C%20KFF%20found
• https://time.com/7311517/cost-weight-loss-drugs-skinny/#:~:text=But%20these%20medications%20were%20originally,diabetes%2C%20weight%20loss%20treatment%20is